A clinical study on NEERCHURUKKU CHOORANAM in the management of NEERCHURUKKU(UTI)

A Prospective open labelled non randomized phase II clinical trial on NEERCHURUKKU CHOORANAM in the management of NEERCHURUKKU(UTI)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031383

Enrollment

Registered

2021-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: NEERCHURUKKU CHOORANAM: 100-150mg/Kg/BW/Twice a day(orally) A/F For 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patient having presence of burning sensation when urinate,discomfort or pain in lower abdomen,an urgent need to urinate,cloudy or bloody urine,foul smell urine, pain in the lower blank, fever and chill.

Exclusion criteria

Exclusion criteria: age below 14 and above 66 years, pregnancy lactating mothers recent malignancy or radio therapy CKD and Kidney disease Diabetic and systemic hypertension chronic Protatis patient considered unreliable by the investigator

Design outcomes

Primary

Measure	Time frame
Reduction of the symptoms of burning sensation when urinating, fever and chill, lower abdominal pain, nausea and vomitingTimepoint: 45 days	—

Secondary

Measure	Time frame
To perform the bio chemical analysis, physico chemical, and phyto chemical analysis To evaluate Pharmacological activity, acute and sub acute toxicity of trial drug NEERCHURUKKU CHOORANAM.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr A Manoharan

Government Siddha Medical College and Hospital

justusantony71@gmail.com9443090849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026